ACCESSION: MSBNK-mFam-MC01_000025
RECORD_TITLE: (3S,5S,8R,9S,10S,13S,14S,17S)-17-((R)-1-hydroxy-1-((2R,5R)-5-methylpiperidin-2-yl)ethyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate; APCI-ITFT; MS2; CE: CID 35;  [M-H]-
DATE: 2023.01.17
AUTHORS: Alena Soboleva, Andrej Frolov
LICENSE: CC BY
PUBLICATION: NA
COMMENT: CONFIDENCE Pure standard
CH$NAME: (3S,5S,8R,9S,10S,13S,14S,17S)-17-((R)-1-hydroxy-1-((2R,5R)-5-methylpiperidin-2-yl)ethyl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
CH$COMPOUND_CLASS: NA
CH$FORMULA: C29H49NO3
CH$EXACT_MASS: 459.37124
CH$SMILES: C[C@@H](CN1)CC[C@@H]1[C@](C)(O)[C@H]2CC[C@@]3([H])[C@]4([H])CC[C@@]5([H])C[C@@H](OC(C)=O)CC[C@]5(C)[C@@]4([H])CC[C@]23C
CH$IUPAC: InChI=1S/C29H49NO3/c1-18-6-11-26(30-17-18)29(5,32)25-10-9-23-22-8-7-20-16-21(33-19(2)31)12-14-27(20,3)24(22)13-15-28(23,25)4/h18,20-26,30,32H,6-17H2,1-5H3/t18-,20+,21+,22+,23+,24+,25+,26-,27+,28+,29-/m1/s1
CH$LINK: INCHIKEY GKNYXIUCYIOHPA-VBEJBQKESA-N
AC$INSTRUMENT: Orbitrap Elite
AC$INSTRUMENT_TYPE: APCI-ITFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: IONIZATION APCI
AC$MASS_SPECTROMETRY: COLLISION_ENERGY CID 35
AC$CHROMATOGRAPHY: COLUMN_NAME Acquity CSHC18
AC$CHROMATOGRAPHY: RETENTION_TIME 0.132 min
MS$FOCUSED_ION: BASE_PEAK 458.36310
MS$FOCUSED_ION: PRECURSOR_M/Z 458.36310
MS$FOCUSED_ION: PRECURSOR_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_INTENSITY 4307708
MS$DATA_PROCESSING: RECALIBRATE loess on assigned fragments and MS1
MS$DATA_PROCESSING: REANALYZE Peaks with additional N2/O included
MS$DATA_PROCESSING: WHOLE RMassBank 3.7.1
PK$SPLASH: splash10-0006-0101900000-7ac3b97225837e92312c
PK$NUM_PEAK: 8
PK$PEAK: m/z int. rel.int.
  138.0923 286 4
  140.1083 10035 160
  317.247 3974 63
  359.2588 8283 132
  403.2603 141 2
  415.0475 112 1
  440.3136 122 1
  442.331 62354 999
//
